PRAX
Praxis Precision Medicines, Inc.$321.55-9.44 (-2.85%)Prev Close$330.99·MCap$7.13B·P/E—·Vol307.5K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
15
$10.77M
◆
Net Activity
Net Seller
$10.77M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Praxis Precision Medicines, Inc. (PRAX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 15 insider sales totaling $10.77M. The most recent insider transaction was by Kelly Timothy Edwin (Chief Financial Officer), who sold $260.0K worth of shares on Jan 12, 2026. Praxis Precision Medicines, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $7.13B.
PRAX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Kelly Timothy Edwin | Chief Financial Officer | Sell | 943 | $275.74 | $260.0K | 0 |
| Jan 12, 2026 | Mastrocola Lauren | Principal Accounting Officer | Sell | 344 | $275.74 | $94.9K | 0 |
| Jan 12, 2026 | Nemiroff Alex | General Counsel and Secretary | Sell | 768 | $275.74 | $211.8K | 0 |
| Jan 12, 2026 | Sniecinski Megan | Chief Operating Officer | Sell | 885 | $275.74 | $244.0K | 0 |
| Jan 8, 2026 | Kelly Timothy Edwin | Chief Financial Officer | Sell | 1,335 | $288.45 | $385.1K | 0 |
| Jan 8, 2026 | Mastrocola Lauren | Principal Accounting Officer | Sell | 367 | $288.45 | $105.9K | 0 |
| Jan 8, 2026 | Nemiroff Alex | General Counsel and Secretary | Sell | 917 | $288.45 | $264.5K | 0 |
| Jan 8, 2026 | Sniecinski Megan | Chief Operating Officer | Sell | 1,087 | $288.45 | $313.5K | 0 |
| Jan 8, 2026 | Souza Marcio | Chief Executive Officer | Sell | 4,252 | $288.45 | $1.23M | 0 |
| Jan 7, 2026 | Kelly Timothy Edwin | Chief Financial Officer | Sell | 139 | $292.63 | $40.7K | 0 |
| Jan 7, 2026 | Mastrocola Lauren | Principal Accounting Officer | Sell | 35 | $292.63 | $10.2K | 0 |
| Jan 7, 2026 | Nemiroff Alex | General Counsel and Secretary | Sell | 89 | $292.63 | $26.0K | 0 |
| Jan 7, 2026 | Souza Marcio | Chief Executive Officer | Sell | 405 | $292.63 | $118.5K | 0 |
| Nov 20, 2025 | Mastrocola Lauren | Principal Accounting Officer | Sell | 13,600 | $192.08 | $2.61M | 0 |
| Nov 20, 2025 | Nemiroff Alex | General Counsel and Secretary | Sell | 25,130 | $193.09 | $4.85M | 0 |
| Nov 15, 2024 | Mastrocola Lauren | Principal Accounting Officer | Sell | 5,188 | $81.78 | $424.3K | 5,613-48% |
| Nov 15, 2024 | Nemiroff Alex | General Counsel and Secretary | Sell | 8,239 | $80.20 | $660.8K | 10,301-44% |
| Oct 10, 2023 | DeSimone Jill | Director | Buy | 14,500 | $1.75 | $25.4K | 14,500 |
| Jun 27, 2023 | Souza Marcio | Chief Executive Officer | Buy | 10,000 | $1.06 | $10.6K | 45,002+29% |
| Mar 27, 2023 | Kelly Timothy Edwin | Chief Financial Officer | Buy | 8,000 | $0.87 | $7.0K | 46,416 |
| Mar 27, 2023 | MITCHELL DEAN J | Director | Buy | 50,000 | $0.84 | $41.8K | 75,000+200% |
| Mar 27, 2023 | Souza Marcio | Chief Executive Officer | Buy | 70,001 | $0.86 | $60.4K | 226,299+45% |
| Jun 21, 2022 | Mastrocola Lauren | Principal Accounting Officer | Buy | 3,000 | $1.93 | $5.8K | 31,391 |
| Jun 14, 2022 | Nemiroff Alex | General Counsel and Secretary | Buy | 7,500 | $1.63 | $12.2K | 39,347 |
| Jun 13, 2022 | Kelly Timothy Edwin | Chief Financial Officer | Buy | 10,000 | $1.77 | $17.6K | 40,490+33% |
| Jun 9, 2022 | MITCHELL DEAN J | Director | Buy | 25,000 | $1.81 | $45.2K | 25,000 |
| Jun 9, 2022 | Souza Marcio | Chief Executive Officer | Buy | 27,000 | $1.85 | $49.9K | 189,184 |
| Oct 8, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 400,000 | $17.50 | $7.00M1.9% OS | 0Exit |
| Oct 5, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 46,546 | $19.14 | $890.9K | 423,946 |
| Sep 2, 2021 | Kelly Timothy Edwin | Chief Financial Officer | Buy | 3,905 | $19.48 | $76.1K | 3,905 |
| Aug 25, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 352,396 | $19.00 | $6.70M1.7% OS | 447,317-44% |
| Aug 20, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 3,000 | $15.88 | $47.6K | 798,942 |
| Aug 19, 2021 | Souza Marcio | Chief Executive Officer | Buy | 9,542 | $15.79 | $150.7K | 86,792 |
| Aug 13, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 27,282 | $14.62 | $398.9K | 812,002 |
| Aug 5, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 22,300 | $14.99 | $334.3K | 829,224 |
| Aug 3, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 55,854 | $15.75 | $879.8K | 891,524 |
PRAX Insider Buying Activity
The following table shows recent insider purchases of Praxis Precision Medicines, Inc. (PRAX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 10, 2023 | DeSimone Jill | Director | Buy | 14,500 | $1.75 | $25.4K | 14,500 |
| Jun 27, 2023 | Souza Marcio | Chief Executive Officer | Buy | 10,000 | $1.06 | $10.6K | 45,002+29% |
| Mar 27, 2023 | Kelly Timothy Edwin | Chief Financial Officer | Buy | 8,000 | $0.87 | $7.0K | 46,416 |
| Mar 27, 2023 | MITCHELL DEAN J | Director | Buy | 50,000 | $0.84 | $41.8K | 75,000+200% |
| Mar 27, 2023 | Souza Marcio | Chief Executive Officer | Buy | 70,001 | $0.86 | $60.4K | 226,299+45% |
| Jun 21, 2022 | Mastrocola Lauren | Principal Accounting Officer | Buy | 3,000 | $1.93 | $5.8K | 31,391 |
| Jun 14, 2022 | Nemiroff Alex | General Counsel and Secretary | Buy | 7,500 | $1.63 | $12.2K | 39,347 |
| Jun 13, 2022 | Kelly Timothy Edwin | Chief Financial Officer | Buy | 10,000 | $1.77 | $17.6K | 40,490+33% |
| Jun 9, 2022 | MITCHELL DEAN J | Director | Buy | 25,000 | $1.81 | $45.2K | 25,000 |
| Jun 9, 2022 | Souza Marcio | Chief Executive Officer | Buy | 27,000 | $1.85 | $49.9K | 189,184 |
| Sep 2, 2021 | Kelly Timothy Edwin | Chief Financial Officer | Buy | 3,905 | $19.48 | $76.1K | 3,905 |
| Aug 19, 2021 | Souza Marcio | Chief Executive Officer | Buy | 9,542 | $15.79 | $150.7K | 86,792 |
PRAX Insider Selling Activity
The following table shows recent insider sales of Praxis Precision Medicines, Inc. (PRAX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Kelly Timothy Edwin | Chief Financial Officer | Sell | 943 | $275.74 | $260.0K | 0 |
| Jan 12, 2026 | Mastrocola Lauren | Principal Accounting Officer | Sell | 344 | $275.74 | $94.9K | 0 |
| Jan 12, 2026 | Nemiroff Alex | General Counsel and Secretary | Sell | 768 | $275.74 | $211.8K | 0 |
| Jan 12, 2026 | Sniecinski Megan | Chief Operating Officer | Sell | 885 | $275.74 | $244.0K | 0 |
| Jan 8, 2026 | Kelly Timothy Edwin | Chief Financial Officer | Sell | 1,335 | $288.45 | $385.1K | 0 |
| Jan 8, 2026 | Mastrocola Lauren | Principal Accounting Officer | Sell | 367 | $288.45 | $105.9K | 0 |
| Jan 8, 2026 | Nemiroff Alex | General Counsel and Secretary | Sell | 917 | $288.45 | $264.5K | 0 |
| Jan 8, 2026 | Sniecinski Megan | Chief Operating Officer | Sell | 1,087 | $288.45 | $313.5K | 0 |
| Jan 8, 2026 | Souza Marcio | Chief Executive Officer | Sell | 4,252 | $288.45 | $1.23M | 0 |
| Jan 7, 2026 | Kelly Timothy Edwin | Chief Financial Officer | Sell | 139 | $292.63 | $40.7K | 0 |
| Jan 7, 2026 | Mastrocola Lauren | Principal Accounting Officer | Sell | 35 | $292.63 | $10.2K | 0 |
| Jan 7, 2026 | Nemiroff Alex | General Counsel and Secretary | Sell | 89 | $292.63 | $26.0K | 0 |
| Jan 7, 2026 | Souza Marcio | Chief Executive Officer | Sell | 405 | $292.63 | $118.5K | 0 |
| Nov 20, 2025 | Mastrocola Lauren | Principal Accounting Officer | Sell | 13,600 | $192.08 | $2.61M | 0 |
| Nov 20, 2025 | Nemiroff Alex | General Counsel and Secretary | Sell | 25,130 | $193.09 | $4.85M | 0 |
| Nov 15, 2024 | Mastrocola Lauren | Principal Accounting Officer | Sell | 5,188 | $81.78 | $424.3K | 5,613-48% |
| Nov 15, 2024 | Nemiroff Alex | General Counsel and Secretary | Sell | 8,239 | $80.20 | $660.8K | 10,301-44% |
| Oct 8, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 400,000 | $17.50 | $7.00M1.9% OS | 0Exit |
| Oct 5, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 46,546 | $19.14 | $890.9K | 423,946 |
| Aug 25, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 352,396 | $19.00 | $6.70M1.7% OS | 447,317-44% |
| Aug 20, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 3,000 | $15.88 | $47.6K | 798,942 |
| Aug 13, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 27,282 | $14.62 | $398.9K | 812,002 |
| Aug 5, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 22,300 | $14.99 | $334.3K | 829,224 |
| Aug 3, 2021 | BSOF Parallel Master Fund L.P. | 10% Owner | Sell | 55,854 | $15.75 | $879.8K | 891,524 |
PRAX Insiders
Similar Stocks to PRAX
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B